Noveris Health Sciences is trading 10.14% up at CA$0.38 after a sharp three-session decline.
- The rebound follows unusually volatile trading, with no clear company-specific catalyst identified for August 10, 2026.
- Management said on August 6 that it was unaware of any material operational change explaining recent market activity.
- Investors may also be awaiting second-quarter results, although earnings timing is not independently confirmed.